Coagulation Analyzer Market Scope And Analysis

  • Report Code : TIPRE00008957
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 205
Buy Now

Coagulation Analyzer Market Scope, Growth, Size and Share by 2030

Buy Now

Coagulation Analyzer Market Report Coagulation Analyzer Market Size and Share Coagulation Analyzer Market Scope and Analysis

Coagulation Analyzer Market Report Scope

Report Attribute Details
Market size in 2022 US$ 4.18 Billion
Market Size by 2030 US$ 6.69 Billion
Global CAGR (2022 - 2030) 6.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product Type
  • Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers
By Test
  • Prothrombin Time Testing
  • Fibrinogen Testing
  • Activated Clotting Time Testing
  • D-Dimer Testing
  • Activated Partial Thromboplastin Time Testing
  • Platelets Function Testing
By Technology
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
By End User
  • Clinical Laboratories
  • Hospital
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Danaher Corp
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc
  • Sysmex Corporation
  • Horiba Ltd
  • Nihon Kohden Corp
  • F Hoffmann La Roche Ltd
  • Maccura Biotechnology Co Ltd

    • The increasing awareness program for blood disorders is likely to the favor market growth for coagulation analyzers. Hemophilia Health Education and Prevention Funded Projects is the largest program in CDC’s division of blood disorders. CDC has funded projects that are designed to promote health and prevent complications related to bleeding disorders.

    Thus, increasing number of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders in the region are anticipated to boost the North America coagulation analyzers market growth during the forecast period.

    The report profiles leading players operating in the global coagulation analyzers market. These involve Abbott Laboratories, Danaher Corp, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corp, F. Hoffmann-La Roche Ltd, Maccura Biotechnology Co Ltd, and Bio Group Medical System SRL.

    In February 2021, Siemens Healthineers and Sysmex Corporation announced the renewal of the companies' long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension. As part of the agreement, Siemens Healthineers will distribute the new Sysmex CN Systems.

    In July 2020, Sysmex announced the launch of a new product- “Automated Blood Coagulation Analyzers CN-6000 and CN-3000” in the EMEA region.

    Company Profiles

    • Abbott Laboratories
    • Danaher Corp
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific Inc
    • Sysmex Corporation
    • Horiba Ltd.
    • Nihon Kohden Corp
    • F. Hoffmann-La Roche Ltd
    • Maccura Biotechnology Co Ltd
    • Bio Group Medical System SRL